Mumbai's COVID-19 cases drop below 2,000; 11 die, active tally at 21,142

This was the sixth day in a row when the daily COVID-19 cases have witnessed a drop in the financial capital. On Sunday, 2,550 COVID-19 cases and 13 deaths were reported in the city.

PTI

January 24, 2022 / 22:17 IST

(Representative image: Reuters)

Mumbai on Monday reported under-2,000 new coronavirus cases at 1,857, down by 693 from the previous day and the lowest daily count in nearly a month, while 11 more patients succumbed to the infection, the city civic body said.

A Brihanmumbai Municipal Corporation (BMC) bulletin said that with these new additions, the city's COVID-19 tally rose to 10,36,690, while the death toll jumped to 16,546.

This was the sixth day in a row when the daily COVID-19 cases have witnessed a drop in the financial capital. On Sunday, 2,550 COVID-19 cases and 13 deaths were reported in the city.

Also, for the first time since December 28, 2021, the daily cases have dipped below the 2,000-mark.On December 29, the city had logged 2,510 COVID-19 cases, while 1,377 cases were reported on the previous day.

In the last 24 hours, 34,301 COVID-19 tests were carried out in the city, taking the tally to 1,50,11,519, the bulletin said.As many as 45,993 tests were conducted on Sunday, it said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show